Changes in collagen content and alignment during rectal tumor progression as observed in our study could be due to the alterations of lysyl oxidase level in the neoplastic ECM which regulates collagen crosslinking as observed in CRC tissue samples (5, 6). The gene discussed is LOX; the disease is colorectal carcinoma.